Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep:77 Suppl 1:S17-29; quiz S30.
doi: 10.1007/s00115-006-2142-7.

[Clinical treatment and therapy for dissected cervicocerebral artery]

[Article in German]
Affiliations
Review

[Clinical treatment and therapy for dissected cervicocerebral artery]

[Article in German]
T Brandt et al. Nervenarzt. 2006 Sep.

Abstract

Dissection of a cervicocerebral artery (CAD) is the second leading cause of stroke at younger ages. The pathogenesis of spontaneous CAD is not fully clarified. Defective connective tissue components may cause an arteriopathy predisposing to CAD in combination with certain trigger and risk factors. The clinical spectrum includes local pain in the neck, headaches, Horner's syndrome, isolated cranial nerve deficits, and hemispheric or brainstem infarction. Noninvasively, CAD is confirmed by Duplex sonography, MRI, and MRA. There is no controlled study for best treatment or management. Rational initial empiric treatment in acute CAD to prevent secondary embolism is partial thromboplastin time-guided anticoagulation by intravenous heparin followed by anticoagulation with warfarin. Carotid surgery for treating CAD is not recommended. The duration of anticoagulation is best guided by Doppler sonography follow-up and should extend until normalization of blood flow or at least 6 months after the vessel was occluded. Caution should be recommended for exercises that involve excessive head movements. The recurrence rate for CAD is low at <1%/year except for patients with known hereditary connective tissue disorders or in cases with familial dissections.

PubMed Disclaimer

References

    1. Arch Neurol. 2005 Jul;62(7):1168-70 - PubMed
    1. J Neurol Sci. 1997 Mar 20;147(1):27-34 - PubMed
    1. Dtsch Med Wochenschr. 1999 Mar 12;124(10 ):273-8 - PubMed
    1. Stroke. 1994 May;25(5):998-1005 - PubMed
    1. Neurology. 2005 May 10;64(9):1612-4 - PubMed

MeSH terms

LinkOut - more resources